The Private Investor Perspective Part One: Canadian VC & PE in 2017 & Beyond

    The Private Investor Perspective Part One: Canadian VC & PE in 2017 & Beyond

This is part one of a new CVCA series, The Private Investor Perspective, which examines the Canadian venture capital and private equity market from the viewpoint of funders. In the

Read Full Article

Venture Capital-backed Zymeworks Goes Public

    Venture Capital-backed Zymeworks Goes Public

Vancouver-based Zymeworks (TSE/NYSE: ZYME) debuted on the public markets last Friday, just two weeks after announcing its intention to go public. The company raised CAD $79.7 million in the IPO

Read Full Article

Three Years Into VCAP and Program Still Propelling Canada’s Innovation Ecosystem

    Three Years Into VCAP and Program Still Propelling Canada’s Innovation Ecosystem

Today, the Canadian Venture Capital and Private Equity Association celebrates the third anniversary of the Government of Canada’s Venture Capital Action Plan (VCAP)– a program that was implemented in January

Read Full Article

Fonds de solidarité invests $4M in Zymeworks

    Fonds de solidarité invests $4M in Zymeworks

Fonds de solidarité FTQ has invested $4 million in common shares of Zymeworks Inc., a biotherapeutics company focused on the

Read Full Article

SIGN UP FOR DAILY DEALS AND NEWS UPDATE

CVCA Events

CVCA on Twitter